CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 21 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $571,000 | – | 46,796 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,857,667 | $22,661,000 | 18.22% |
| Clarus Ventures, LLC | 2,752,488 | $21,827,000 | 15.30% |
| Camber Capital Management LP | 1,000,000 | $7,930,000 | 0.51% |
| Rhenman & Partners Asset Management AB | 306,227 | $2,428,000 | 0.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 643,580 | $5,104,000 | 0.21% |
| SPHERA FUNDS MANAGEMENT LTD. | 80,742 | $640,000 | 0.09% |
| Spark Investment Management LLC | 23,100 | $183,000 | 0.02% |
| FRED ALGER MANAGEMENT, LLC | 157,782 | $1,251,000 | 0.01% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 45,000 | $357,000 | 0.01% |
| FEDERATED HERMES, INC. | 80,000 | $634,000 | 0.00% |